ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

PHARM Pharming Group NV

0.90
0.019 (2.16%)
26 Abr 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Pharming Group NV PHARM Euronext Acción Ordinaria
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.019 2.16% 0.90 10:40:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.888 0.8825 0.903 0.90 0.881
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
24/4/202401:00GLOBEPharming Group to report first quarter 2024 financial..
24/4/202400:00GLOBEPharming to be honored as Industry Innovator at National ..
19/4/202411:43GLOBEPharming Group announces the repurchase of outstanding €125..
18/4/202408:04GLOBEPharming Group announces the placement of €100 million..
18/4/202401:00GLOBEPharming Group announces the launch of an offering of..
08/4/202400:00GLOBEPharming announces completion of enrollment in pediatric..
04/4/202401:30GLOBEPharming Group announces the 2024 Annual General Meeting of..
04/4/202400:00GLOBEPharming Group announces the filing of its 2023 Annual..
03/4/202401:00GLOBEPharming Group to participate in April investor conferences
14/3/202401:00GLOBEPharming Group reports fourth quarter and full year 2023..
29/2/202401:00GLOBEPharming Group to report fourth quarter and full year 2023..
08/2/202401:00GLOBEPharming Group to participate in February investor..
08/1/202400:00GLOBEPharming Group announces updated full year 2023 guidance and..
13/12/202300:00GLOBEPharming Group announces development plans for leniolisib..
21/11/202300:00GLOBEPharming announces first patient dosed in pediatric clinical..
10/11/202307:51GLOBEPharming Group provides updates on EMA regulatory review of..
01/11/202302:00GLOBEPharming Group to participate in November investor..
26/10/202300:00GLOBEPharming Group reports third quarter 2023 financial results
12/10/202301:00GLOBEPharming Group to report third quarter 2023 financial..
25/9/202309:00GLOBEPharming Group reports on results of the 2023 Extraordinary..

Su Consulta Reciente

Delayed Upgrade Clock